Fresenius Medical Care AG (FMS)

NYSE: FMS · Real-Time Price · USD

22.51

-0.11 (-0.49%)

At close: Apr 28, 2026, 4:00 PM EDT

22.51

0.00 (0.00%)

After-hours: Apr 28, 2026, 7:00 PM EDT

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 30, which predicts an increase of 33.27% from the current stock price of 22.51.

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$30	$30	$30	$30
Change	+33.27%	+33.27%	+33.27%	+33.27%

* Price targets were last updated on May 12, 2025.

Analyst Ratings

The average analyst rating for Fresenius Medical Care AG stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graham Doyle UBS	UBS	Hold → Strong Sell Downgrades n/a	Hold → Strong Sell	Downgrades	n/a	n/a	Sep 2, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $25 → $30	Hold	Maintains	$25 → $30	+33.27%	May 12, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $23 → $25	Hold	Maintains	$23 → $25	+11.06%	Jan 6, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	+2.18%	Oct 7, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $24 → $22	Hold	Maintains	$24 → $22	-2.27%	Jul 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

19.59B

from 19.63B

-0.22%

from 19.63B

Revenue Next Year

20.34B

from 19.59B

3.83%

from 19.59B

EPS This Year

4.12

from 3.36

22.51%

from 3.36

EPS Next Year

4.51

from 4.12

9.69%

from 4.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	17.62B	19.40B	19.45B	19.34B	19.63B	19.59B	20.34B
Revenue Growth	-1.35%	10.10%	0.29%	-0.61%	1.51%	-0.22%	3.83%
EPS	3.31	2.30	1.70	1.83	3.36	4.12	4.51
EPS Growth	-16.44%	-30.60%	-25.97%	7.65%	83.60%	22.51%	9.69%
Forward PE	-	-	-	-	-	4.67	4.25
No. Analysts	-	-	-	-	-	24	22

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	20.9B	22.1B
Avg	19.6B	20.3B
Low	18.6B	19.2B

Revenue Growth

Revenue Growth	2026	2027
High	6.6%	12.7%
Avg	-0.2%	3.8%
Low	-5.2%	-1.8%

EPS Forecast

EPS	2026	2027
High	4.73	5.30
Avg	4.12	4.51
Low	3.78	3.73

EPS Growth

EPS Growth	2026	2027
High	40.6%	28.7%
Avg	22.5%	9.7%
Low	12.6%	-9.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.